碎石
发表于 2025-3-30 08:59:00
Von der , zur Vielfalt der Kämpfeucleotides that can specifically bind to their targets. They are promising alternatives of antibodies in the field of medical devices owing to the property of specific binding to their targets, as well as the advantages such as easy synthesis and modification, chemical stability, low immunogenicity,
rheumatology
发表于 2025-3-30 12:32:03
Karolin Kalmbach,Elke Kleinau,Susanne Völkerathy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmac
optional
发表于 2025-3-30 16:54:36
http://reply.papertrans.cn/17/1605/160479/160479_53.png
无法取消
发表于 2025-3-30 21:20:26
Karolin Kalmbach,Elke Kleinau,Susanne Völkerlogical information have been successfully applied in infection diagnosis. However, these methods are either relatively complicated or time-consuming. Aptamer, a specific DNA/RNA binder, can serve as field-deployable sensors (termed aptasensors), and is thus highly promising to construct point-of-us
技术
发表于 2025-3-31 03:20:08
http://reply.papertrans.cn/17/1605/160479/160479_55.png
DALLY
发表于 2025-3-31 08:22:35
Von der , zur Vielfalt der Kämpfe (AMI), acute coronary syndromes (ACS), and thrombotic diseases. Nowadays, thrombotic diseases are the leading causes of morbidity and mortality which incur substantial healthcare expenditures worldwide. There are some shortcomings for current antithrombotics including bleeding potential, unpredicta